| 000 | 01867 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516144234.0 | ||
| 264 | 0 | _c20140211 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a2072-6805 | ||
| 024 | 7 |
_a10.3126/nepjoph.v5i1.7824 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThapa, R | |
| 245 | 0 | 0 |
_aShort term results of intra-vitreal bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. _h[electronic resource] |
| 260 |
_bNepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH _c |
||
| 300 |
_a63-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aFundus Oculi |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 |
_aMacular Edema _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRetinal Vein Occlusion _xcomplications |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aVisual Acuity |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPoudyal, G | |
| 773 | 0 |
_tNepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH _gvol. 5 _gno. 1 _gp. 63-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3126/nepjoph.v5i1.7824 _zAvailable from publisher's website |
| 999 |
_c22668046 _d22668046 |
||